Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.
about
Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.Nanomaterials for cancer immunotherapy.Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
P2860
Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting Treg cells in situ: ...... +)CD25(+)) regulatory T cells.
@en
Targeting Treg cells in situ: emerging expansion strategies for
@nl
type
label
Targeting Treg cells in situ: ...... +)CD25(+)) regulatory T cells.
@en
Targeting Treg cells in situ: emerging expansion strategies for
@nl
prefLabel
Targeting Treg cells in situ: ...... +)CD25(+)) regulatory T cells.
@en
Targeting Treg cells in situ: emerging expansion strategies for
@nl
P2093
P2860
P1476
Targeting Treg cells in situ: ...... +)CD25(+)) regulatory T cells.
@en
P2093
Alwi Shatry
Jackeline Chirinos
Monica Jones
Robert B Levy
P2860
P304
P356
10.1016/J.BBMT.2009.06.009
P577
2009-08-03T00:00:00Z